Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC

Lung Cancer

Volumn 78, Issue 1, 2012, Pages 87-91

  Grimminger, Peter P ^a   Maus, Martin K H ^a   Schneider, Paul M ^b   Metzger, Ralf ^a   Hölscher, Arnulf H ^a   Sugita, Hirofumi ^c   Danenberg, Peter V ^c   Alakus, Hakan ^a   Brabender, Jan ^d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d St Antonius Krankenhaus Kon   (Germany)

Author keywords

DNA methylation; GST PI; MRNA expression; Non small cell lung cancer (NSCLC)

Indexed keywords

GLUTATHIONE TRANSFERASE; MESSENGER RNA;

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DNA METHYLATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEX RATIO;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE S-TRANSFERASE PI; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; RNA, MESSENGER;

EID: 84866166176     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.07.008     Document Type: Article

References (34)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics. CA Cancer J Clin 2009.
2. SEER cancer statistics review 2008, National Cancer Institute, Bethesda, MD, pp.1975-2005. L.A.G. Ries, D. Melbert, M. Krapcho, D.G. Stinchcomb, N. Howlader, M.J. Horner, A. Mariotto, B.A. Miller, E.J. Feuer, S.F. Altekruse, D.R.C.L. Lewis, M.P. Eisner, M. Reichman, B.K. Edwards (Eds.).
3. Brabender J., Vallbohmer D., Grimminger P., Hoffmann A.C., Ling F., Lurje G., et al. ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus. J Gastrointest Surg 2008, 12:1815-1821.
4. Kim Y.C., Park K.O., Kern J.A., Park C.S., Lim S.C., Jang A.S., et al. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients. Lung Cancer 1998, 22:181-190.
5. Kwiatkowski D.J., Harpole D.H., Godleski J., Herndon J.E., Shieh D.B., Richards W., et al. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. J Clin Oncol 1998, 16:2468-2477.
6. Lord R.V., Brabender J., Gandara D., Alberola V., Camps C., Domine M., et al. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin Cancer Res 2002, 8:2286-2291.
7. Vallbohmer D., Lenz H.J. Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus 2006, 19:425-432.
8. Miao X.P., Li J.S., Li H.Y., Zeng S.P., Zhao Y., Zeng J.Z. Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions. World J Gastroenterol 2007, 13:2867-2871.
9. Strauss G.M., Kwiatkowski D.J., Harpole D.H., Lynch T.J., Skarin A.T., Sugarbaker D.J. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol 1995, 13:1265-1279.
10. Brabender J., Danenberg K.D., Metzger R., Schneider P.M., Park J., Salonga D., et al. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res 2001, 7:1850-1855.
11. Brabender J., Park J., Metzger R., Schneider P.M., Lord R.V., Holscher A.H., et al. Prognostic significance of cyclooxygenase 2mRNA expression in non-small cell lung cancer. Ann Surg 2002, 235:440-443.
12. Grimminger P., Ling F.C., Neiss S., Vallbohmer D., Lurje G., Schneider P.M., et al. The role of the homeobox genes BFT and CDX2 in the pathogenesis of non-small cell lung cancer. Anticancer Res 2009, 29:1281-1286.
13. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994, 54:4313-4320.
14. Arai T., Yasuda Y., Takaya T., Hayakawa K., Toshima S., Shibuya C., et al. Immunohistochemical expression of glutathione transferase-PI in untreated primary non-small-cell lung cancer. Cancer Detect Prev 2000, 24:252-257.
15. Hida T., Ariyoshi Y., Kuwabara M., Sugiura T., Takahashi T., Hosoda K., et al. Glutathione S-transferase PI levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity. Jpn J Clin Oncol 1993, 23:14-19.
16. Bai F., Nakanishi Y., Kawasaki M., Takayama K., Yatsunami J., Pei X.H., et al. Immunohistochemical expression of glutathione S-transferase PI can predict chemotherapy response in patients with nonsmall cell lung carcinoma. Cancer 1996, 78:416-421.
17. Shiga H., Heath E.I., Rasmussen A.A., Trock B., Johnston P.G., Forastiere A.A., et al. Prognostic value of p53, glutathione S-transferase PI, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res 1999, 5:4097-4104.
18. Tidefelt U., Elmhorn-Rosenborg A., Paul C., Hao X.Y., Mannervik B., Eriksson L.C. Expression of glutathione transferase PI as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res 1992, 52:3281-3285.
19. McGown A.T., Fox B.W. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 1986, 17:223-226.
20. Robson C.N., Lewis A.D., Wolf C.R., Hayes J.D., Hall A., Proctor S.J., et al. Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity. Cancer Res 1987, 47:6022-6027.
21. Schisselbauer J.C., Silber R., Papadopoulos E., Abrams K., LaCreta F.P., Tew K.D. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res 1990, 50:3562-3568.
22. Teicher B.A., Holden S.A., Kelley M.J., Shea T.C., Cucchi C.A., Rosowsky A., et al. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res 1987, 47:388-393.
23. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
24. Lord R.V., Salonga D., Danenberg K.D., Peters J.H., DeMeester T.R., Park J.M., et al. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 2000, 4:135-142.
25. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res 1996, 6:995-1001.
26. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res 1996, 6:986-994.
27. Pike M.C. Asymptomatically efficient rank invariant procedures. J R Stat Soc Series A 1972, 135:201-203.
28. Miller R., Siegmund D. Maximally selected chi-square statistics. Biometrics 1982, 38:1011-1016.
29. Halpern J. Maximally selected chi-square statistics for small samples. Biometrics 1982, 38:1017-1023.
30. Wang J., Zhang J., Zhang L., Zhao L., Fan S., Yang Z., et al. Expression of P-gp, MRP, LRP, GST-PI and TopoIIalpha and intrinsic resistance in human lung cancer cell lines. Oncol Rep 2011, 26:1081-1089.
31. Vlachogeorgos G.S., Manali E.D., Blana E., Legaki S., Karagiannidis N., Polychronopoulos V.S., et al. Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: association with response to treatment and survival. Cancer 2008, 114:519-526.
32. Brabender J., Usadel H., Metzger R., Schneider P.M., Park J., Salonga D., et al. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. Clin Cancer Res 2003, 9:223-227.
33. Usadel H., Brabender J., Danenberg K.D., Jeronimo C., Harden S., Engles J., et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002, 62:371-375.
34. Hoffmann A.C., Kaifi J.T., Vallbohmer D., Yekebas E., Grimminger P., Leers J.M., et al. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GST-PI in patients with non-small cell lung cancer. J Surg Oncol 2009, 100:414-417.